In a new #COVID19 study, Cheryl Ainslie-Cameron and I collaborated with clinical & computational colleagues around the world to hone in on a panel of dysfunctional immune signals that may undermine patient recovery from the most severe forms of COVID-19 illness.
An artificial neural network classification method employing longitudinally monitored immune biomarkers to predict the clinical outcome of critically ill COVID-19 patients. Research Article
Comments